Creavo Medical Technologies is an innovative British company developing diagnostics technology for acute medical settings.

The company was set up to commercialise technology that was developed at the University of Leeds by Professor Ben Varcoe that will revolutionise front-line patient triage for chest pain; speeding decision-making, offering better patient management and crucially saving time and NHS resources.


Further Information

Interview: Prof Mark Kearney

Professor Mark Kearney talks about current guidelines and their implications.

Reducing diagnosis time for potential cardiac conditions

Watch Creavo Medical Technologies in a current-affairs style programme produced by ITN Productions in partnership with the NHS Alliance.

Interview: Dr Francis Morris

Dr Francis Morris talks about identifying patients with heart attacks.

Latest News


Creavo Medical Technologies secures U.S. FDA 510(k)

Technology has the potential to revolutionise emergency department triage of chest pain patients. Developer of innovative medical diagnostic technology, Creavo Medical Technologies, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The move opens the U.S. market for its portable scanning device, Vitalscan, and demonstrates an increasing industry focus on the global … Continue reading Creavo Medical Technologies secures U.S. FDA 510(k)


Read the ‘Full Hearts’ article in CEO Magazine featuring Creavo’s CEO, Steve Parker

Our CEO, Steve Parker, was interviewed for a feature in this October’s CEO Magazine, where he discussed our device and its potentially game-changing technology. With Steve’s vast experience in the medtech industry, it makes for an interesting read. Take a look at the online version here.


European Society for Emergency Medicine Congress 2017

Creavo will be attending the European Society for Emergency Medicine in Athens from 24 – 27 September. Come and visit us on stand H11, we would love to hear from you!


Read our CSO’s latest blog in the Huffpost

Our Chief Scientific Officer, Professor Ben Varcoe, has written a blog on HuffPost about how our device uses magnetocardiography to help rule out cardiac conditions in chest pain patients, helping to combat the volume of them put through the lengthy A&E triage process. Click here to find out more.


European Society of Cardiology Congress 2017

Creavo will be attending the European Society of Cardiology in Barcelona from 26 – 30 August. Come and visit us on stand H650, we would love to hear from you!


New device can rule out heart attacks in 3-5 minutes, saving £200m a year

We recently spoke to medical news website, Building Better Healthcare, about Vitalscan and how its technology has the potential to revolutionise the treatment of chest pain patients in A&E departments. Read more here.